These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25149900)

  • 61. Anti-invasive effects of CXCR4 and FAK inhibitors in non-small cell lung carcinomas with mutually inactivated p53 and PTEN tumor suppressors.
    Dragoj M; Bankovic J; Sereti E; Stojanov SJ; Dimas K; Pesic M; Stankovic T
    Invest New Drugs; 2017 Dec; 35(6):718-732. PubMed ID: 28733702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
    Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
    Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Wang J; Qi Q; Huang B; Chen A; Li X; Wang J
    Oncol Rep; 2016 Oct; 36(4):2160-8. PubMed ID: 27498786
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sirtuin 6 inhibits colon cancer progression by modulating PTEN/AKT signaling.
    Tian J; Yuan L
    Biomed Pharmacother; 2018 Oct; 106():109-116. PubMed ID: 29957460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line.
    Moon SH; Kim DK; Cha Y; Jeon I; Song J; Park KS
    Int J Oncol; 2013 Mar; 42(3):921-8. PubMed ID: 23314408
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.
    Zhang Y; Zhang J; Xu K; Xiao Z; Sun J; Xu J; Wang J; Tang Q
    Hepatogastroenterology; 2013 Oct; 60(127):1766-72. PubMed ID: 24624456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.
    Kang YJ; Balter B; Csizmadia E; Haas B; Sharma H; Bronson R; Yan CT
    Nat Commun; 2017 Jan; 8():14013. PubMed ID: 28094268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of drebrin in glioma migration and invasion.
    Terakawa Y; Agnihotri S; Golbourn B; Nadi M; Sabha N; Smith CA; Croul SE; Rutka JT
    Exp Cell Res; 2013 Feb; 319(4):517-28. PubMed ID: 23201135
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Mar; 30(9):1020-31. PubMed ID: 20972462
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.
    Guillamo JS; de Boüard S; Valable S; Marteau L; Leuraud P; Marie Y; Poupon MF; Parienti JJ; Raymond E; Peschanski M
    Clin Cancer Res; 2009 Jun; 15(11):3697-704. PubMed ID: 19435839
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extracellular matrix 1 (ECM1) regulates the actin cytoskeletal architecture of aggressive breast cancer cells in part via S100A4 and Rho-family GTPases.
    Gómez-Contreras P; Ramiro-Díaz JM; Sierra A; Stipp C; Domann FE; Weigel RJ; Lal G
    Clin Exp Metastasis; 2017 Jan; 34(1):37-49. PubMed ID: 27770373
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway.
    Wang P; Guan Q; Zhou D; Yu Z; Song Y; Qiu W
    DNA Cell Biol; 2018 Jan; 37(1):38-45. PubMed ID: 29185784
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polyploid/Multinucleated Giant and Slow-Cycling Cancer Cell Enrichment in Response to X-ray Irradiation of Human Glioblastoma Multiforme Cells Differing in Radioresistance and TP53/PTEN Status.
    Alhaddad L; Chuprov-Netochin R; Pustovalova M; Osipov AN; Leonov S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Icaritin inhibits the invasion and epithelial-to-mesenchymal transition of glioblastoma cells by targeting EMMPRIN via PTEN/AKt/HIF-1α signalling.
    Xu B; Jiang C; Han H; Liu H; Tang M; Liu L; Ji W; Lu X; Yang X; Zhang Y; Liu Y
    Clin Exp Pharmacol Physiol; 2015 Dec; 42(12):1296-307. PubMed ID: 26356761
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines.
    Lim HJ; Wang X; Crowe P; Goldstein D; Yang JL
    Anticancer Res; 2016 Nov; 36(11):5765-5771. PubMed ID: 27793898
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduction of Akt2 inhibits migration and invasion of glioma cells.
    Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
    Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model.
    Pei J; Park IH; Ryu HH; Li SY; Li CH; Lim SH; Wen M; Jang WY; Jung S
    Radiat Oncol; 2015 Aug; 10():164. PubMed ID: 26245666
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of key genetic mutations on increasing migration of brain cancer cells through confinement.
    Bui L; Bhuiyan SH; Hendrick A; Chuong CJ; Kim YT
    Biomed Microdevices; 2017 Sep; 19(3):56. PubMed ID: 28620782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.